Background--Wall shear stress (WSS) is an established predictor of coronary atherosclerosis progression. Prior studies have reported that high WSS has been associated with high-risk atherosclerotic plaque characteristics (APCs). WSS and APCs are quantifiable by coronary computed tomography angiography, but the relationship of coronary lesion ischemia-evaluated by fractional flow reserve-to WSS and APCs has not been examined.
A therosclerosis is a major cause of cardiovascular disease and is the foremost cause of morbidity and mortality worldwide. 1, 2 Endothelial wall shear stress (WSS) reflects a parallel hemodynamic force that resides within the endothelial surface of the arterial wall. 3 By a complex array of cellular, molecular, and biochemical reactions, WSS affects the structure of blood vessels. [4] [5] [6] Prior studies have documented that high WSS is a key component in atherosclerotic plaque destabilization, arterial wall remodeling, and atherosclerosis progression. [7] [8] [9] Coronary computed tomography angiography (CCTA) is a noninvasive imaging method that enables determination of anatomic atherosclerotic plaque characteristics (APCs), including coronary stenosis severity, arterial positive remodeling (PR), low-attenuation plaque (LAP), and spotty calcification (SC). [10] [11] [12] Recent developments in computational fluid dynamics (CFD) applied to CCTA enable determination of physiological coronary processes, including WSS. 13 Fractional flow reserve (FFR) represents the current gold standard for determining coronary lesion-specific ischemia, and its use to guide decision making for coronary revascularization results in improved event-free survival. 14 Prior reports have elicited stenosis severity and APCs by CCTA to be important and independent factors for identification of ischemia-causing lesions compared with FFR. 15, 16 To date, the association of WSS to CCTA APCs and coronary ischemia has not been evaluated. Consequently, we sought to evaluate the independent relationship between WSS and coronary ischemia as determined by FFR, the reference standard.
Methods Study Population
The DeFACTO (Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography; NCT01233518) study is a prospective multicenter trial performed at 17 centers in 5 countries (Canada, n=1; Belgium, n=1; Latvia, n=1; South Korea, n=2; and United States, n=12). 17 For the purpose of this investigation, 100
patients with suspected coronary artery disease enrolled in the DeFACTO trial were selected from a post hoc sample size calculation and subsequently evaluated. Invasive coronary angiography (ICA) with intended FFR was performed within 60 days of CCTA, and no intervening coronary events were observed. Patients were not deemed eligible for participation if they had a prior history of coronary artery bypass grafting, percutaneous coronary intervention with suspected in-stent restenosis based on CCTA findings, contraindication to adenosine, suspicion of or recent acute coronary syndrome, complex congenital heart disease, pacemaker or defibrillator, prosthetic heart valve, significant arrhythmia, serum creatinine level >1.5 mg/dL, allergy to iodinated contrast, pregnant state, body mass index >35, evidence of active clinical instability or life-threatening disease, or an inability to adhere to study procedures. The appropriate institutional review board committees approved the study protocol, and all patients provided written informed consent. 
ICA and FFR Measurement

Calculation of Endothelial WSS From CCTA
Patient-specific 3-dimensional geometry of the coronary artery was reconstructed from CCTA imaging data. Following the 3-dimensional reconstruction, blood flow simulations were performed by solving Navier-Stokes equations. WSS by CFD analysis involved 3 primary steps: (1) volumetric coronary tree mesh generation, (2) specification of physiological boundary conditions for blood flow simulations, and (3) numerical computation of WSS by solving of the Navier-Stokes equations. Hyperemic resistances were prescribed by reducing the microcirculatory resistances in accordance with the effects of adenosine. 20 WSS was calculated from the velocity solution at each mesh point on the lateral wall and was postprocessed and rendered with a blue-to-red color map for visual analysis in ParaView (www.paraview.org) ( Figure 1 ).
Coregistration Between CCTA and the 3-Dimensional Reconstructed WSS Model
In total, 100 patients (n=163 coronary lesions) with evaluable CCTAs were indiscriminately selected for calculation of WSS. Stenotic lesions were determined by semiquantitative assessment using 3-dimensional reconstructed coronary geometries, and corresponding lesions were identified in ICA images with invasive FFR evaluation. For each lesion, a sphere with a radius of 0.5 cm was placed at the center of the maximal stenosis as a region of interest. The magnitude of the WSS within each region of interest was calculated. The mean of the calculated magnitude was used to define the average level of WSS for a particular lesion. For the purpose of this study, the mean of WSS was categorized according to tertiles.
Statistical Methods
Continuous variables are expressed as meanAESD, and categorical variables are reported as counts with proportions.
Comparisons between WSS groups were assessed by use of a 1-way ANOVA for continuous variables in which subsequent multiple pairwise comparisons were adjusted using the Sidak method and Pearson's chi-square test for categorical variables. The Student unpaired t test was performed for comparison of covariates between 2 groups. Correlation analysis was performed using Pearson's correlation coefficient, whereas adjusted linear regression reporting b coefficients and standard errors was also performed to report the linear relationship between WSS and ICA stenosis. Logistic regression analyses reporting odds ratios with 95% CIs were performed to predict the likelihood of having APCs according to the WSS groups. Candidate variables related to coronary stenosis (ie, minimal lumen area, MLD, area stenosis, diameter stenosis) and each APC (ie, PR, LAP, and SC) were tested for entry to the multivariate model, with P<0.1 for association with WSS; next, backward-stepwise regression was performed to construct a multivariate model with a threshold of P<0.05. 21, 22 After an elimination approach, MLD was selected in variables related to coronary stenosis, and PR and LAP were selected in variables related to APCs. WSS was combined with stenosis severity in model 1, with APCs in model 2, and with both stenosis severity and APCs in model 3.
The receiver operating characteristic curve was fashioned to evaluate the discriminatory ability of WSS for predicting ischemia, and areas under the receiver operating characteristic curve were compared using the method described by DeLong et al. 23 The latter method is a nonparametric test for comparing correlated areas under the receiver operating characteristic curve by using the generalized U statistics to generate an estimated covariance matrix. For the primary hypothesis of an association between WSS and FFR, sample size calculation was performed using a 2-sided sample equal variance test with WSS as a categorical variable. We estimated that 34 lesions were required to achieve a statistical power of 80% with an a level of 0.05. For the A B Figure 1 . A, Color-encoded wall shear stress based on a 3-dimensional model by coronary computed tomography angiography. B, Zoomed image for coronary atherosclerotic lesion.
secondary hypothesis of an association between WSS and APCs, we estimated that 41 lesions for PR, 34 lesions for LAP, and 42 lesions for SC were required to detect a statistical power of 80% with an a level of 0.05, based on the equality of 2 independent proportions test. A 2-tailed P<0.05 was considered statistically significant. All statistical analyses were performed using STATA version 13 (StataCorp LP).
Results
The mean age of the current study population was 62.8AE9.1 years, and the study sample was predominantly male (70%) ( (Figure 2A ). The correlation coefficient between WSS and ICA stenosis displayed significant correlation (r=0.341, P<0.001) (Figure 2B) . Multivariable linear regression revealed that WSS was an independent predictor of increasing ICA stenosis (eg, Figure 3A ). Increasing numbers of intraplaque APCs were associated with high WSS (P=0.006) ( Figure 3B ). The odds of PR or LAP presence, as well as the presence of any APC feature, were higher in the highest WSS group compared with the lowest WSS group (Table 3) . SC was not associated with WSS groups in univariable or multivariable models ( 
Discussion
In this present study, high WSS was independently associated with stenosis severity and APCs. In particular, high WSS portended %2.5-fold increased odds of PR and LAP presence, even after adjustment of coronary stenosis severity. In contrast, WSS was not an independent predictor of coronary ischemia and added no predictive value for determining ischemia beyond stenosis severity and APCs. To our knowledge, these data are the first to explore the relationship between APCs and WSS for precise identification of coronary lesions with significant ischemia by invasive FFR and to refute the notion that WSS can be used as a diagnostic parameter for improved discrimination of ischemia-causing coronary lesions by CCTA. Previous studies have reported that high WSS is closely related to high-risk APCs. Samady and colleagues reported that high WSS assessed by intravascular ultrasound images is associated with longitudinal development of high-risk APCs, including intraplaque necrotic core or expansive arterial remodeling. 8 Indeed, the incidence of expansive remodeling in high WSS coronary segments is 2-fold higher compared with low WSS segments. Noninvasive imaging has been similarly examined for these findings. Hetterich and coworkers reported the feasibility of applying CFD techniques to CCTA for determining WSS. 24 In their study, higher WSS was associated with APCs and vessel wall thickness. Our present study findings directly expand on these data by demonstrating that high WSS is related to the presence of APCs and is inversely proportional to FFR values. This direct relationship, however, is not an independent factor deserving of consideration for identification of coronary artery lesions that cause ischemia. In this present study, it is unsurprising that WSS is directly related to coronary lesion stenosis severity because WSS is a direct product of hemodynamic blood flow. 25 For APCs, this information was heretofore unclear. We assessed 3 APCs that were previously identified as being directly related to ischemia and incremental to stenosis severity for enhanced diagnosis compared with an invasive FFR reference standard (eg, PR, LAP, and SC). 16 Although beyond the scope of this study, there is an array of possible cellular explanations for these study findings. Germane to PR, high WSS stimulates endothelial macrophages, which in turn produce metalloproteinases. 26 These metalloproteinases further increase the extraluminal area and remodeling index in lesions with high WSS. 27, 28 High WSS also suppresses vascular smooth muscle cell proliferation and induces apoptosis by augmenting transforming growth factor b and nitric oxide within endothelial cells. 29, 30 These processes potentially contribute to transformation of APCs to a more high-risk state in which LAP, a CCTA surrogate of intraplaque necrotic core, may be more likely present. Early studies have suggested SC as another high-risk plaque associated with coronary ischemia, although more recent studies have negated this view. [31] [32] [33] The relationship between SC and other important coronary artery disease findings, including ischemia and future acute coronary syndromes, does not yet appear to be fully defined. In the current study, PR and LAP were found to be associated with high WSS, whereas SC did not display any notable relationship in lesions with either low or high WSS. Yet, high WSS promotes vascular calcification by increasing the expression of bone morphogenic protein 4, and it seems reasonable to consider SC an imaging surrogate of such a process. 34 It is possible-and may be likely, based on the current study results-that this is a parallel process that occurs in association with the development and presence of PR and LAP but is less influential in the development of ischemia. Prior studies have examined the relationship of APCs to coronary ischemia independent of stenosis severity. 16 These
APCs add to CFD-based calculations of FFR from CCTA. Although the precise mechanisms of how APCs may adversely affect hemodynamics have not been fully explored, it is possible that they represent imaging surrogate markers of local coronary cellular and biochemical responses at the endothelial layer. 35, 36 In aggregate, these data combined with the present study findings suggest that CFD-based assessment of CCTA for coronary ischemia should be limited to FFR from CCTA and APCs, with little attention needing to be paid to WSS for measures of ischemia. In hindsight, these findings are perhaps intuitive, given that the driving forces of translesional hyperemic flow-as measured by FFR from CCTA-are orders of magnitude higher than WSS and are more likely to explain the ischemia process. Despite the "negative" findings that WSS do not incrementally contribute to the definition of coronary ischemia, these study findings are nevertheless essential to our understanding of the prioritization of CCTA image analyses, given the detailed and time-consuming process of WSS calculations.
Limitations
This study is not without limitations. Although this study comprised patients derived from a prospective multicenter international study, they were nevertheless representative of an indiscriminately selected group, and as such, we cannot discount the possible occurrence of a selection bias. Nevertheless, to our knowledge, this study is the largest study population size designed to investigate WSS by CFD-based application to noninvasive CCTA. The cross-sectional nature of this study limits our inference of the potential causal relationship between WSS and plaque morphology. In the present study, APCs were available only as dichotomous categorical measures. Consequently, the quantitative assessment of APCs (eg, LAP volume and remodeling index) and their possible relationship with WSS warrants further investigation. According to sample size calculations, our study sample was sufficiently sized to assess the relationship of WSS groups with FFR, PR, and LAP. Nevertheless, it bears mentioning that the relationship with SC was somewhat underpowered because SC lesions in the current study failed to exceed the number required to test for statistical significance; therefore, caution should be taken when interpreting our findings related with SC. Prior invasive studies suggest the importance of low, in addition to high, WSS for atherosclerosis progression. 7, 8 Moreover, the pathophysiological understanding of WSS and its levels as a function of high-risk APCs and atherosclerosis progression require further investigation. The calculation of WSS was derived from CCTA images and was not validated against an invasive reference standard. Yet prior studies demonstrate feasibility and generally high accuracy for CFD applied to CCTA, and in this study, we expected similar performance. 13, 37 Finally, the current study was performed using a simulation of mean time-averaged flow as opposed to a pulsatile simulation over a cardiac cycle. WSS is a dynamic phenomenon that is further affected by a host of factors that alter endothelial function, and our study was unable to account for all potential contributory factors. Consequently, the present study was unable to calculate perhaps more informative variables related to shear stress, including timevarying WSS, or oscillatory shear index. Future studies examining these metrics now appear warranted.
Conclusion
In this study, we identified high WSS to be directly related to the presence and number of APCs; however, high WSS was not independently associated with coronary lesion ischemia.
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